Treatment of mice with a ?friendly? bacteria, normally found in the soil, altered their behavior in a way similar to that produced by antidepressant drugs, reports research published in the latest issue of Neuroscience.
43 people, including 11 children, were told in Auckland that they were operated on with the same surgical instruments as a woman diagnosed as having symptoms consistent with sporadic CJD.
Combining two different types of treatment for migraine results in better symptom relief than taking either one of the medications, according to a study in the April 4 issue of JAMA.
Patients with early-stage breast cancer who are treated with both chemotherapy and tamoxifen have a higher survival rate than patients who receive only tamoxifen.
Women who initiate hormone therapy closer to menopause tend to have a reduced risk of coronary heart disease compared to women who begin treatment further from menopause, but researchers did not find this reduced risk was statistically significant, according to a study in the April 4 issue of JAMA.
In a ceremony, Gov. Bill Richardson signed into law a bill that makes New Mexico the 12th state to protect seriously ill patients from arrest for using medical marijuana with a doctor’s recommendation – prompting Minnesota lawmakers to call for similar protections here.
Emerging genetic research may help scientists recognize children with autism at a younger and potentially treatable age, according to an editorial in the April issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
The American College of Physicians (ACP) released a new clinical practice guideline for screening mammography for women 40 to 49 years of age.
The number of people in the U.S. with macular degeneration is greater than that with all types of cancer combined. Macular degeneration can lead to blindness, something that people fear even more than premature death. This award will help further research into this condition.
The largest retrospective, observational study comparing two osteoporosis therapies on the basis of fracture reduction was presented today at the Seventh European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO) in Porto, Portugal.